Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 96-103

  Van Den Anker Lugtenburg, P J ^a   Krenning, E P ^a   Oei, H Y ^a   Van Hagen, M P ^a   Gerrits, C J H ^a   Reubi, J C ^b   Lamberts, S W J ^a   Lowenberg B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Hodgkin's disease; octreotide; scintigraphy; somatostatin; somatostatin receptor; staging of Hodgkin's disease

Indexed keywords

INDIUM 111; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCINTIGRAPHY;

ADOLESCENT; ADULT; AGED; FEMALE; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY;

EID: 0029916144     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.443986.x     Document Type: Article

References (26)

1. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor positive tumors: radiolabeling and in vitro validation. Life Sciences, 49, 1583-1591.
2. Bares, R., Galonska, P., Dempke, W., Handt, S., Bull, U. & Osieka, R. (1993) Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Hormone and Metabolic Research Supplement, 27, 56-58.
3. Bong, S.B., VanderLaan, J.G., Louwes, H. & Schuurman, J.J. (1994) Clinical experience with somatostatin receptor imaging in lymphoma. Seminars in Oncology Supplement, 21, 46-50.
4. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. & Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Research, 31, 1860-1861.
5. Front, D. & Israel, O. (1995) The role of Ga-67 scintigraphy in evaluating the results of therapy in lymphoma patients. Seminars in Nuclear Medicine, 25, 60-71.
6. Front, D., Israel, O., Epelbaum, R., Ben Haim, S., Even Sapir, E., Jerushalmi, J., Kolodny, G.M. & Robinson, E. (1990) Ga-67 SPECT before and after treatment of lymphoma. Radiology, 175, 515-519.
7. Hagemeister, F.B., Fesus, S.M., Lamki, L.M. & Haynie, T.P. (1990) Role of the gallium scan in Hodgkin's disease. Cancer, 65, 1090-1096.
8. Krenning, E.P., Bakker, W.H., Breeman, W.A.P., Koper, J.W., Kooij, P.P.M., Ausema, L., Lameris, J.S., Reubi, J.C. & Lamberts, S.W.J. (1989) Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet, i, 242-244.
9. Krenning, E.P., Bakker, W.H., Kooij, P.P.M., Breeman, W.A.P., Yoe Oei, H., de Jong, M., Reubi, J.C., Visser, T.J., Bruns, C., Kwekkeboom, D.J., Reijs, A.E.M., van Hagen, P.M., Koper, J.W. & Lamberts, S.W.J. (1992) Somatostatin receptor scintigraphy with Indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with Iodine-123-Tyr-3-octreotide. Journal of Nuclear Medicine, 33, 652-658.
10. 3]-octreotide: the Rotterdam experience with more than 1000 patients. European Journal of Nuclear Medicine, 20, 716-731.
11. Krenning, E.P., Kwekkeboom, D.J., de Jong, M., Visser, T.J., Reubi, J.C., Bakker, W.H., Kooij, P.P.M & Lamberts, S.W.J. (1994) Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide. Seminars in Oncology, 21, 6-14.
12. Krenning, E.P., Kwekkeboom, D.J., Lamberts, S.W.J., Pauwels, S., Kvols, L. & Reubi, J.C. (1995) Somatostatin receptor scintigraphy. Nuclear Medicine Annual (ed. by L. M. Freeman), pp. 1-50. Raven Press, New York.
13. Kwekkeboom, D.J., Krenning, E.P., Bakker, W.H., Yoe Oei, H., Kooij, P.P.M. & Lamberts, S.W.J. (1993) Somatostatin analogue scintigraphy in carcinoid tumours. European Journal of Nuclear Medicine, 20, 283-292.
14. Lamberts, S.W.J., Bakker, W.H., Reubi, J.C. & Krenning, E.P. (1990) Somatostatin-receptor imaging in the localization of endocrine tumors. New England Journal of Medicine, 323, 1246-1249.
15. Lipp, R.W., Silly, H., Ranner, G., Dobnig, H., Passath, A., Leb, G. & Krejs, G.J. (1995) Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. Journal of Nuclear Medicine, 36, 13-18.
16. North, L.B. & Jing, B.S. (1988) Imaging procedures. Hodgkin's Disease and Non-Hodgkin's Lymphomas in Adults and Children (ed. by L. Fuller), pp. 130-169. Raven Press, New York.
17. Reubi, J.C., Heitz, P.U. & Landolt, A.M. (1987) Visualization of Somatostatin receptors and correlation with immunoreactive GH and PRL in human pituitary adenomas: evidence for different tumor subclasses. Journal of Clinical Endocrinology and Metabolism, 65, 65-73.
18. Reubi, J.C., Kvols, L.K., Waser, B., Nagorney, D.M., Heitz, P.U., Charboneau, J.W., Reading, C.C. & Moertel, C. (1990a) Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Research, 50, 5959-5977.
19. Reubi, J.C., Maurer, R., Klijn, J.G.M., Stefanko, S.Z., Foekens, J.A., Blaauw, G., Blankenstein, M.A. & Lamberts, S.W.J. (1986) High incidence of somatostatin receptors in human meningiomas: biochemical characterization. Journal of Clinical Endocrinology and Metabolism, 63, 433-438.
20. Reubi, J.C., Waser, B., Foekens, J.A., Klijn, J.G.M. Lamberts, S.W.J. & Laissue, J. (1990b) Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF-receptors. International Journal of Cancer, 46, 416-420.
21. Reubi, J.C., Waser, B., Horisberger, IL, Krenning, E., Lamberts, S.W.J., Gebbers, J.O., Gersbach, P. & Laissue, J.A. (1993) In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood, 82, 2143-2151.
22. Reubi, J.C., Waser, B., Sheppard, M. & Macaulay, V. (1990c) Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. International Journal of Cancer, 45, 269-274.
23. Reubi, J.C., Waser, B., van Hagen, M., Lamberts, S.W.J., Krenning, E.P., Gebbers, J.O. & Laissue, J.A. (1992) In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. International Journal of Cancer, 50, 895-900.
24. van Eijck, C.H.J., Krenning, E.P., Bootsma, A., Yoe Oei, H., van Pel, R., Lindemans, J., Jeekel, J., Reubi, J.C. & Lamberts, S.W.J. (1994) Somatostatin receptor scintigraphy in primary breast cancer. Lancet, 343, 640-643.
25. van Hagen, P.M., Krenning, E.P., Reubi, J.C., Mulder, A.H., Bakker, W.H., Yoe Oei, H., Löwenberg, B. & Lamberts, S.W.J. (1993) Somatostatin analogue scintigraphy of malignant lymphomas. British Journal of Haematology, 83, 75-79.
26. Vanhagen, P.M., Krenning, E.P., Reubi, J.C., Kwekkeboom, D.J., Bakker, W.H., Mulder, A.H., Laissue, L. Hoogstede, H.C. & Lamberts, S.W.J. (1994) Somatostatin analogue scintigraphy in granulomatous diseases. European Journal of Nuclear Medicine, 21, 497-502.